Alt a 1 Promotes Allergic Asthma In Vivo Through TLR4-Alveolar Macrophages

The mold Alternaria alternata is one of the main sources of asthma exacerbation, being its major allergen, Alt a 1, indispensable for its development. The main objective of this work was to answer two main questions: 1) can Alt a 1 by itself (without any other context) induce an asthmatic profile in...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in immunology Vol. 13; p. 877383
Main Authors: Hernandez-Ramirez, Guadalupe, Pazos-Castro, Diego, Gonzalez-Klein, Zulema, Resuela-Gonzalez, Jose Luis, Fernandez-Bravo, Sergio, Palacio-Garcia, Lucia, Esteban, Vanesa, Garrido-Arandia, Maria, Tome-Amat, Jaime, Diaz-Perales, Araceli
Format: Journal Article
Language:English
Published: Frontiers Media S.A 30-06-2022
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The mold Alternaria alternata is one of the main sources of asthma exacerbation, being its major allergen, Alt a 1, indispensable for its development. The main objective of this work was to answer two main questions: 1) can Alt a 1 by itself (without any other context) induce an asthmatic profile in vivo ?; and 2) Which molecular mechanisms take place during this phenomenon? To answer both questions, we have developed a mouse model of allergic asthma using only Alt a 1 for mice sensitization. We also made use of in-vitro cellular models and computational studies to support some aspects of our hypothesis. Our results showed that Alt a 1 can induce an asthmatic phenotype, promoting tissue remodeling and infiltration of CD45+ cells, especially eosinophils and macrophages (Siglec F+ and F4/80+). Also, we have found that Alt a 1 sensitization is mediated by the TLR4-macrophage axis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
This article was submitted to Molecular Innate Immunity, a section of the journal Frontiers in Immunology
Edited by: Cong-Yi Wang, Tongji Medical College, China
Reviewed by: Fei Sun, Tongji Medical College, China; Weining Xiong, Shanghai Ninth People’s Hospital Ninth, China
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2022.877383